Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

SN Hashemi1, HR Ghafarian Shirazi2,3, A Mohamadi4, GH Zadeh-Bagheri5, KH Noorian5, M Malekzadeh21Department of Psychiatry, Faculty of Medicine, 2Research Center of Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, 3School of Public Health, Tehran University of Medical Sci...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/aa5de16937bf4b1aa6e3426acefbb133
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:aa5de16937bf4b1aa6e3426acefbb133
record_format	dspace
spelling	oai:doaj.org-article:aa5de16937bf4b1aa6e3426acefbb1332021-12-02T06:45:23ZNortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial1179-1438https://doaj.org/article/aa5de16937bf4b1aa6e3426acefbb1332012-01-01T00:00:00Zhttp://www.dovepress.com/nortriptyline-versus-fluoxetine-in-the-treatment-of-major-depressive-d-a9150https://doaj.org/toc/1179-1438SN Hashemi1, HR Ghafarian Shirazi2,3, A Mohamadi4, GH Zadeh-Bagheri5, KH Noorian5, M Malekzadeh21Department of Psychiatry, Faculty of Medicine, 2Research Center of Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, 3School of Public Health, Tehran University of Medical Sciences, Tehran, 4Department of Psychiatry, 5School of Medicine, Yasuj University of Medical Sciences, Yasuj, IranBackground: Depression is a common psychiatric disorder worldwide, including in Iran, and is estimated to affect 10%&ndash;15% of the population. Antidepressant drugs can have multiple side effects, so a good choice of drug is important for successful treatment. This study compared the efficacy of nortriptyline with that of fluoxetine in the treatment of patients with major depressive disorder and assessed related factors, including age, gender, and level of education.Methods: The study was a double-blind, randomized clinical trial with a six-month follow-up period. Participants were 120 patients aged 15&ndash;60 years with a diagnosis of major depressive disorder based on a psychiatry interview and the Beck depression rating scale, which were performed at the beginning, middle, and end of the study. The patients were treated with nortriptyline or fluoxetine. The paired t-test, independent t-test, and the k chi-square test were used to analyze the data.Results: Twenty-three patients dropped out and 97 remained in the trial. Before intervention, the mean depression score was 32.85 &plusmn; 6.23 in the nortriptyline group and 33.12 &plusmn; 6.50 in the fluoxetine group. The results of the independent t-test showed a significant difference between depression score means before and after treatment in both groups. Changes at the end of the trial compared with baseline scores were 13.4 &plusmn; 4.68 and 16.96 &plusmn; 4.96 for nortriptyline and fluoxetine, respectively. Paired t-testing showed a significant difference in the mean depression score for both the nortriptyline and fluoxetine groups. Age, gender, and level of education had no significant effects on the outcome of treatment in the two groups.Conclusion: The present study suggests that both nortriptyline and fluoxetine were effective in the treatment of depression, but that fluoxetine was more effective than nortriptyline after 3 and 6 months of treatment.Keywords: major depressive disorder, nortriptyline, fluoxetine, treatmentHashemi SNGhafarian Shirazi HRMohammadi AZadeh-Bagheri GHNoorian KHMalekzadeh MDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol 2012, Iss default, Pp 1-6 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Therapeutics. Pharmacology RM1-950
spellingShingle	Therapeutics. Pharmacology RM1-950 Hashemi SN Ghafarian Shirazi HR Mohammadi A Zadeh-Bagheri GH Noorian KH Malekzadeh M Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
description	SN Hashemi1, HR Ghafarian Shirazi2,3, A Mohamadi4, GH Zadeh-Bagheri5, KH Noorian5, M Malekzadeh21Department of Psychiatry, Faculty of Medicine, 2Research Center of Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, 3School of Public Health, Tehran University of Medical Sciences, Tehran, 4Department of Psychiatry, 5School of Medicine, Yasuj University of Medical Sciences, Yasuj, IranBackground: Depression is a common psychiatric disorder worldwide, including in Iran, and is estimated to affect 10%&ndash;15% of the population. Antidepressant drugs can have multiple side effects, so a good choice of drug is important for successful treatment. This study compared the efficacy of nortriptyline with that of fluoxetine in the treatment of patients with major depressive disorder and assessed related factors, including age, gender, and level of education.Methods: The study was a double-blind, randomized clinical trial with a six-month follow-up period. Participants were 120 patients aged 15&ndash;60 years with a diagnosis of major depressive disorder based on a psychiatry interview and the Beck depression rating scale, which were performed at the beginning, middle, and end of the study. The patients were treated with nortriptyline or fluoxetine. The paired t-test, independent t-test, and the k chi-square test were used to analyze the data.Results: Twenty-three patients dropped out and 97 remained in the trial. Before intervention, the mean depression score was 32.85 &plusmn; 6.23 in the nortriptyline group and 33.12 &plusmn; 6.50 in the fluoxetine group. The results of the independent t-test showed a significant difference between depression score means before and after treatment in both groups. Changes at the end of the trial compared with baseline scores were 13.4 &plusmn; 4.68 and 16.96 &plusmn; 4.96 for nortriptyline and fluoxetine, respectively. Paired t-testing showed a significant difference in the mean depression score for both the nortriptyline and fluoxetine groups. Age, gender, and level of education had no significant effects on the outcome of treatment in the two groups.Conclusion: The present study suggests that both nortriptyline and fluoxetine were effective in the treatment of depression, but that fluoxetine was more effective than nortriptyline after 3 and 6 months of treatment.Keywords: major depressive disorder, nortriptyline, fluoxetine, treatment
format	article
author	Hashemi SN Ghafarian Shirazi HR Mohammadi A Zadeh-Bagheri GH Noorian KH Malekzadeh M
author_facet	Hashemi SN Ghafarian Shirazi HR Mohammadi A Zadeh-Bagheri GH Noorian KH Malekzadeh M
author_sort	Hashemi SN
title	Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
title_short	Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
title_full	Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
title_fullStr	Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
title_full_unstemmed	Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
title_sort	nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/aa5de16937bf4b1aa6e3426acefbb133
work_keys_str_mv	AT hashemisn nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial AT ghafarianshirazihr nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial AT mohammadia nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial AT zadehbagherigh nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial AT nooriankh nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial AT malekzadehm nortriptylineversusfluoxetineinthetreatmentofmajordepressivedisorderasixmonthdoubleblindclinicaltrial
_version_	1718399771467579392

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Ejemplares similares